| TTM
|
9/30/2025
|
9/30/2024
|
9/30/2023
|
9/30/2022
|
|
|---|---|---|---|---|---|
| Total Revenue
|
68,184 | 91,290 | 113,381 | 93,307 | 52,580 |
|
Cost of Revenue
|
-64,385 | -84,897 | -97,314 | -76,060 | -36,386 |
|
Gross Profit
|
3,799 | 6,393 | 16,067 | 17,247 | 16,194 |
| Selling, General and Administrative Expenses
|
-32,194 | -47,156 | -42,265 | -22,587 | -21,656 |
|
Research and Development Expenses
|
-13,615 | -13,042 | -10,126 | -7,447 | -7,434 |
|
Operating Income/Expenses
|
-45,809 | -60,198 | -52,391 | -30,034 | -29,090 |
|
Total Operating Profit/Loss
|
-42,010 | -53,805 | -36,324 | -12,787 | -12,896 |
| Total Net Finance Income/Expense
|
-3,895 | -2,742 | -1,512 | -982 | -8,228 |
|
Rental Income
|
0 | -- | 0 | 10,603 | 10,603 |
| Irregular Income/Expenses
|
-3,984 | -3,984 | -475 | -3,694 | -2,906 |
|
Other Income/Expense, Non-Operating
|
2,027 | 2,274 | 57,050 | 69,691 | 15,738 |
|
Non-Operating Income/Expenses, Total
|
-5,852 | -4,452 | 55,063 | 75,618 | 15,207 |
|
Pretax Income
|
-47,862 | -58,257 | 18,739 | 62,831 | 2,311 |
|
Provision for Income Tax
|
297 | 293 | -61 | -162 | 14 |
|
Net Income from Continuing Operations
|
-47,565 | -57,964 | 18,678 | 62,669 | 2,325 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
-47,565 | -57,964 | 18,678 | 62,669 | 2,325 |
|
Non-Controlling/Minority Interests
|
5,442 | 4,636 | 2,034 | -7,337 | -8,590 |
|
Net Income after Non-Controlling/Minority Interests
|
-42,123 | -53,328 | 20,712 | 55,332 | -6,265 |
|
Net Income Available to Common Stockholders
|
-42,123 | -53,328 | 20,712 | 55,332 | -6,265 |
|
Diluted Net Income Available to Common Stockholders
|
-42,123 | -53,328 | 20,712 | 55,332 | -6,265 |
| Basic EPS
|
-4.78 | -7.12 | 3.21 | 8.45 | -1.09 |
| Diluted EPS
|
-4.78 | -7.12 | 3.20 | 8.43 | -1.09 |
|
Basic Weighted Average Shares Outstanding
|
9,853.6350 | 7,490.6710 | 6,459.1890 | 6,546.1530 | 5,773.0940 |
|
Diluted Weighted Average Shares Outstanding
|
9,853.6350 | 7,490.6710 | 6,465.3700 | 6,562.2780 | 5,773.0940 |
| Income Statement, Supplemental
|
|||||
|
EBIT
|
-43,967 | -55,515 | 20,251 | 63,813 | 10,539 |
|
EBITDA
|
-43,967 | -52,313 | 23,080 | 67,844 | 14,440 |
|
Normalized EBITDA
|
-39,983 | -25,166 | -36,083 | 5,098 | 18,596 |
|
Normalized Income
|
-43,605.7207 | -31,088.4700 | -40,292.4244 | 84.7592 | 4,818.6000 |
|
Total Unusual Items
|
3,984 | 27,147 | -59,163 | -62,746 | 4,156 |
9/30/2022 - 3/29/2004
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade